Concepedia

Author

Xiangzheng Liu

Peking UniversityORCID

Also Known As

XIANGZHENG LIU, Xiang-Zheng Liu, Xiang-zheng Liu, XiangZheng Liu, Xiangzheng Liu

35

Publications

238

Citations

7

H-Index

16

Concepts

All Affiliations

Peking UniversityPeking University First HospitalVeterans Health AdministrationUniversity of Maryland, Baltimore
XL

About

Xiangzheng Liu is an author at Peking University specializing in rna biology, gene expression, and non-coding rna.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

1

1

19

2

Medicine

1

1

19

3

Cell Biology

1

1

19

4

Gastroenterology

1

1

19

5

Immunology

1

1

19

Xiangzheng Liu

×

7

Publications

196

Citations

7

H-Index

YearCitations

Interaction between HuR and <i>circPABPN1</i> Modulates Autophagy in the Intestinal Epithelium by Altering ATG16L1 Translation

Xiao-Xue Li, Lan Xiao, Hee Kyoung Chung,

Molecular and Cellular Biology

2020

81

The diagnostic value of the combination of carcinoembryonic antigen, squamous cell carcinoma-related antigen, CYFRA 21-1, neuron-specific enolase, tissue polypeptide antigen, and progastrin-releasing peptide in small cell lung cancer discrimination

Zhimao Chen, Xiangzheng Liu, Xueqian Shang,

The International Journal of Biological Markers

2021

31

The Prognosis and Immune Checkpoint Blockade Efficacy Prediction of Tumor-Infiltrating Immune Cells in Lung Cancer

Xiangzheng Liu, Xueqian Shang, Jian Li,

Frontiers in Cell and Developmental Biology

2021

19

Long noncoding RNA uc.230/CUG-binding protein 1 axis sustains intestinal epithelial homeostasis and response to tissue injury

Tingxi Yu, Sudhakar Kalakonda, Xiangzheng Liu,

JCI Insight

2022

19

Targeting HCCR expression resensitizes gastric cancer cells to chemotherapy via down-regulating the activation of STAT3

Junling Zhang, Xiangzheng Liu, Peng‐Yuan Wang,

Scientific Reports

2016

18

Paxillin is positively correlated with the clinicopathological factors of colorectal cancer, and knockdown of Paxillin improves sensitivity to cetuximab in colorectal cancer cells

Chuang Du, Xin Wang, Junling Zhang,

Oncology Reports

2015

17

BCL2A1 and CCL18 Are Predictive Biomarkers of Cisplatin Chemotherapy and Immunotherapy in Colon Cancer Patients

Taohua Yue, Xiangzheng Liu, Shuai Zuo,

Frontiers in Cell and Developmental Biology

2022

11

Page 1